BMO Capital Reiterates Outperform Rating, $330 Price Target on Eli Lilly (LLY) on Earnings, Highlights "Strong Obesity Data"
Go back to BMO Capital Reiterates Outperform Rating, $330 Price Target on Eli Lilly (LLY) on Earnings, Highlights "Strong Obesity Data"| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1220.28 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1220.28 | 52 Week High | $88.16 | |||
| Open | $1220.28 | 52 Week Low | $67.88 | |||
| Day High | $1220.28 | P/E | 282.47 | |||
| Day Low | $1220.28 | EPS | $4.32 | |||
| Volume | 9,793 | |||||

